Results 81 to 90 of about 39,898 (187)

Seizure outcome after switching antiepileptic drugs: A matched, prospective study. [PDF]

open access: yes, 2016
OBJECTIVE: Outcomes after changing antiepileptic drugs (AEDs) have largely been studied in single cohort series. We recently reported the first study to examine this question in a controlled manner.
Finamore, Jon Marc   +5 more
core   +2 more sources

Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study [PDF]

open access: yes, 2015
OBJECTIVES: Currently, there are no published randomised, controlled veterinary trials evaluating the efficacy of antiepileptic medication in the treatment of myoclonic seizures.
Bessant, C   +5 more
core  

Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019) [PDF]

open access: yes, 2019
The broad interdisciplinary nature of biocatalysis fosters innovation, as different technical fields are interconnected and synergized. A way to depict that innovation is by conducting a survey on patent activities.
Alcántara, Andrés R.   +2 more
core   +3 more sources

A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy

open access: yesNeuropsychiatric Disease and Treatment, 2018
Lanlan Zhang,1 Chengzhong Wang,1 Wei Li2 1Department of Pediatric Neurology, Yancheng Maternal and Child Health Hospital, 2Department of Medical Imaging, Jiangsu Vocational College of Medicine, Yancheng, China Objective: To evaluate clinical efficacy ...
Zhang LL, Wang CZ, Li W
doaj  

Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence. [PDF]

open access: yes, 2011
Two years after the warning issued by the Food and Drug Administration on an increased risk of suicide for people taking antiepileptic drugs (AEDs), a number of pharmacoepidemiologic studies have been published but the scientific community is far from ...
Hesdorffer, DC, Mula, M
core   +3 more sources

Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum

open access: yesParkinson's Disease, 2015
L-DOPA-induced dyskinesias (LID) remain a major problem of long-term therapy of Parkinson’s disease. Levetiracetam, a new antiepileptic drug, has been shown to reduce LID, but the mechanisms underlying its effects are unknown.
Huan Du   +7 more
doaj   +1 more source

Pharmacotherapy for neonatal seizures: current knowledge and future perspectives [PDF]

open access: yes, 2016
Seizures are the most common neurological emergencies in the neonatal period and are associated with poor neurodevelopmental outcomes. Seizures affect up to five per 1000 term births and population-based studies suggest that they occur even more ...
Boylan, Geraldine B.   +4 more
core   +1 more source

Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents. [PDF]

open access: yes, 2017
Newer antiepileptic drugs (AEDs) are increasingly prescribed; however, relatively limited data are available regarding their use in status epilepticus (SE) and the impact on outcome.
Beuchat, I., Novy, J., Rossetti, A.O.
core   +1 more source

Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis

open access: yesFrontiers in Neurology
ObjectiveSeizures are one of the most common symptoms in patients with brain tumor. The efficacy of prophylactic antiepileptic agents in reducing postoperative seizures in patients with brain tumor remains disputed.
Yongyi Zhang   +4 more
doaj   +1 more source

Transport of BMAA into Neurons and Astrocytes by System x\u3csub\u3ec\u3c/sub\u3e- [PDF]

open access: yes, 2018
The study of the mechanism of β-N-methylamino-l-alanine (BMAA) neurotoxicity originally focused on its effects at the N-methyl-d-aspartate (NMDA) receptor. In recent years, it has become clear that its mechanism of action is more complicated.
Albano, Rebecca, Lobner, Doug
core   +1 more source

Home - About - Disclaimer - Privacy